'$GBT FDA filing plan for a sickle cell drug is riskier than you think statnews.com/2018/09/13/glo… I was bullish on Global Blood and voxelotor, now I'm not so sure. I have concerns about the company's strategy shift.'-STAT's Adam Feuerstein Tweets

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!